-
Battle Creek Enquirer - Wed Dec 2, 5:04 pm ET
National Institutes of Health chief Francis Collins today announced the first 13 human embryonic stem cell "lines" approved for federal research funding, under new rules put forward by the Obama Administration this year.
-
The Washington Times - Wed Dec 2, 6:08 pm ET
Scientists got a green light Wednesday to apply for use of 13 embryonic stem cell lines from an approved list developed by the U.S. National Institutes of Health, the government's prime medical research agency. In making the announcement, Dr. Francis S. Collins, NIH director, said that the decision was in accord with guidelines adopted in July and that more lines are likely to be added in the ...
-
UPI - Thu Dec 3, 11:33 am ET
CHICAGO, Dec. 3 (UPI) -- Chicago heart researchers say they've determined adult stem cells might help repair heart tissues damaged by a heart attack.
-
Science Daily - Sun Nov 29, 12:27 am ET
Stem cell scientists have modified a human embryonic stem cell (hESC) line to glow red when the stem cells become red blood cells. The modified hESC line, ErythRED, represents a major step forward to the eventual aim of generating mature, fully functional red blood cells from human embryonic stem cells.
-
KCBS Radio San Francisco - Wed Dec 2, 9:15 pm ET
Embryonic stem cell research is taking another leap forward as the government has approved 13 lines of master cells for federally-funded study. KCBS’ Melissa Culross Reports
-
KPBS San Diego - Wed Dec 2, 9:03 am ET
SAN DIEGO — Stem cell research offers great promise for people with incurable diseases. But promises won't help those who don't have time to wait for those medical breakthroughs. A man, dying of Lou Gehrig's disease, has gone out of the country in search of treatment.
-
Nasdaq - Wed Dec 2, 1:32 pm ET
WASHINGTON -(Dow Jones)- National Institutes of Health Director Francis S. Collins said the agency has approved 13 human embryonic stem cells for research that were created in a manner that was "beyond reproach" and "ethically defensible."
-
Local Tech Wire - Wed Dec 2, 2:34 pm ET
Get the latest news alerts: Follow LTW at Twitter. WASHINGTON - Scientists can start using taxpayer dollars to do research with 13 batches of embryonic stem cells and the government says dozens more cell lines should be available soon, opening a new era for the potentially life-saving field.
-
Rocky Mount Telegram - Wed Dec 2, 2:57 pm ET
WASHINGTON — Shares of companies developing stem cell therapies surged Wednesday on news that ...
-
WBBM Newsradio 780 Chicago - Fri Dec 4, 10:07 am ET
CHICAGO (AP) -- Recent heart attack patients are being sought for an experimental adult stem cell treatment that's had early success. In a preliminary study, stem cells from donor bone marrow appeared to grow new blood vessels bringing more oxygen to the heart.
-
WebMD - Tue Dec 1, 2:54 pm ET
An "off-the-shelf" stem-cell product -- Prochymal -- is safe in heart attack patients. The cells home to and repair injured parts of the heart, an early clinical trial suggests.
-
Business Wire via Yahoo! Finance - Wed Dec 2, 4:13 pm ET
NAPLES, Fla.----Regenocyte Therapeutic has announced results for the successful treatment of cardiomyopathy for retired high school teacher, Leonard Narracci. In this ground-breaking treatment, he was injected with his own stem cells by Regenocyte Therapeutic, headquartered in Bonita Springs, Florida, and has experienced remarkable improvement in his condition.
-
PRWeb via Yahoo! News - Fri Dec 4, 2:00 am ET
A Clinical Study Showing Autologous Stem Cells Trasplant via Minimally Invasive Approaches was Presented in the Parkinson's Study Group Meeting last October in Baltimore, MD.
-
PRWeb - Wed Dec 2, 5:24 pm ET
Emerge Labs presents a revolutionary technology that protects skin stem cells and combats chronological aging. (PRWeb Dec 2, 2009) Read the full story at http://www.prweb.com/releases/2009/12/prweb3270684.htm
-
GenomeWeb News - Thu Dec 3, 12:15 pm ET
New embryonic stem cell lines have been approved for use in federally-funded research in the US. Of these 13 new lines, 11 were made by Harvard Stem Cell Institute's George Daley and the other two by Rockefeller University's Ali Brivanlou. Both researchers used private funds for that work.